BrainStorm Cell Therapeutics
BCLI
#10282
Rank
ยฃ6.19 M
Marketcap
ยฃ0.56
Share price
0.00%
Change (1 day)
-53.68%
Change (1 year)

Market capitalization of BrainStorm Cell Therapeutics (BCLI)

Market cap: ยฃ6.19 Million

As of March 2026 BrainStorm Cell Therapeutics has a market cap of ยฃ6.19 Million. This makes BrainStorm Cell Therapeutics the world's 10282th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BrainStorm Cell Therapeutics from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ6.19 M11.26%
2025ยฃ5.57 M-49.96%
2024ยฃ11.13 M6.09%
2023ยฃ10.49 M-78.81%
2022ยฃ49.53 M-53.92%
2021ยฃ0.10 B-7.9%
2020ยฃ0.11 B54.31%
2019ยฃ75.63 M30.29%
2018ยฃ58.05 M6.22%
2017ยฃ54.65 M42.07%
2016ยฃ38.46 M6.92%
2015ยฃ35.98 M-22.99%
2014ยฃ46.72 M142.9%
2013ยฃ19.23 M-7.11%
2012ยฃ20.7 M24.88%
2011ยฃ16.58 M40.58%
2010ยฃ11.79 M-3.8%
2009ยฃ12.26 M442.15%
2008ยฃ2.26 M

End of Day market cap according to different sources

On Mar 11th, 2026 the market cap of BrainStorm Cell Therapeutics was reported to be:

ยฃ4.4 Million
by Nasdaq info icon info icon
ยฃ6.19 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Biogen
BIIB
ยฃ20.32 B 327,780.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ135.03 B 2,178,064.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
ยฃ32.32 B 521,339.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
ยฃ5.53 B 89,190.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ80.67 M 1,201.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
ยฃ8.18 B 131,986.66%๐Ÿ‡บ๐Ÿ‡ธ USA